Revolutionizing Surgical Hemostasis: Introducing Surgi-ORC® Powder (Absorbable Hemostatic Powder)

Surgi-ORC® Powder

 In modern surgery, efficiently managing perioperative bleeding is crucial. Uncontrolled surgical bleeding poses significant risks to patient health and leads to substantial clinical and healthcare resource burdens. This challenge is particularly pronounced with an aging population and the rising prevalence of comorbidities and anticoagulant use. To address these issues, topical hemostatic agents have emerged as vital tools, promoting hemostasis where conventional methods fall short. These agents vary widely in properties, mode of action, ease of use, safety, and cost. Their selection often depends on the specific surgical scenario, bleeding situation, and patient’s health status.

Exploring Topical Hemostatic Agents

The current array of topical hemostatic agents comprises several types, each designed to meet different needs in the surgical setting:

Mechanical Agents: these are regarded as the simplest, safest, and most cost-effective. They offer a structural framework for hemostasis and are particularly useful in providing immediate bleeding control.

Active Agents: these utilize human, bovine, or recombinant thrombin. They actively engage the clotting process, making them effective in more challenging bleeding scenarios where mechanical agents might not suffice.

Gelatin-Thrombin Matrix Agents (Flowables): these combine gelatin and thrombin to provide a more adaptable solution that can conform to irregular wound surfaces, enhancing the hemostatic effect.

Sealants: made from human fibrinogen or (semi)synthetic compounds, sealants form a fibrin clot that helps stop bleeding and can also promote tissue healing.

Among these, absorbable hemostatic powders stand out as revolutionary products designed to optimize surgical outcomes. Powdered hemostats are especially advantageous for their ease of use and efficacy in controlling continuous oozing bleeding of mild to moderate intensity over large surfaces [1, 2]. Their versatility and effectiveness make them an essential component in the surgical toolkit.

The Game-Changer: Surgi-ORC® Powder

Aegis Lifesciences is pleased to introduce Surgi-ORC® powder, an absorbable hemostat made from natural, plant-based oxidized regenerated cellulose, providing an effective solution for bleeding control.Surgi-ORC® Powder, in particular, is a natural, plant-based absorbable hemostat made from oxidized regenerated cellulose. It is specifically designed for faster control of continuous bleeding across broad surfaces and is suitable for both open and laparoscopic procedures.

Imagine a powder prefilled in a bellow bottle/applicator, ready to dispense directly onto a target bleeding site. Surgi-ORC® Powder is white with a pale yellow color and has a faint, caramel-like aroma. It effectively controls capillary, venous, and small arterial haemorrhage and is fully absorbable. Surgi-ORC® Powder achieves hemostasis faster than other variants of Surgi-ORC® products.

Why Choose Surgi-ORC® Powder?

Composition and safety: made from oxidized regenerated cellulose, Surgi-ORC® Powder ensures biocompatibility and safety. Being a natural, plant-based absorbable haemostat, it contains no animal-origin or collagen additives, making it suitable for patients with allergies or sensitivities.

Ease of application: versatility is key. Surgi-ORC® Powder can be applied dry, directly onto bleeding areas or organs, making it suitable for various surgical procedures.

Rapid haemostasis: time is of the essence in surgery. Surgi-ORC® Powder stops bleeding within minutes, which is crucial for complex surgeries to prevent complications.

Absorbable and biocompatible: fully absorbable with minimal tissue reaction, Surgi-ORC® Powder reduces the risk of post-operative complications.

Antibacterial properties: the low pH of Surgi-ORC® Powder provides an antibacterial effect, reducing the risk of post-operative infections.

Convenience: stored at room temperature and ready-to-use without any preparation, Surgi-ORC® Powder enhances surgical efficiency.

Durability in hemostasis: Surgi-ORC® Powder is designed to maintain hemostasis even under irrigation, ensuring stability during surgical procedures.

Mechanism of action

When Surgi-ORC® Powder comes into contact with blood, it forms a brownish or black gelatinous mass. This mass acts as a physical matrix to which platelets can adhere. As platelet aggregation occurs and a platelet-fibrin plug forms, the swelling material generates pressure on the surrounding tissue, contributing to haemostasis. Excess haemostat can be removed by irrigation with sterile water or saline solution after bleeding has stopped without disturbing the clot.

 

Surgi-ORC® powder Usage area

Simple, Fast, and Safe Application

Applying Surgi-ORC® Powder is straightforward. Due to its structure and penetrating ability, it may not require manual compression, making it optimal for minimally invasive procedures or open surgeries where manual compression is difficult to achieve.

Conclusion

Surgi-ORC® Powder represents a paradigm shift in surgical hemostasis, offering surgeons a reliable and efficient solution to manage perioperative bleeding. With its exceptional performance, user-friendly attributes, and demonstrated efficacy, Surgi-ORC® Powder is set to redefine standards in perioperative bleeding management, ensuring safer and more efficient surgical outcomes for patients worldwide.

Comments

Post a Comment

Popular posts from this blog

Comprehensive Health Check-Up: A Commitment to Employee Well-Being

Image
Introduction In today’s fast-paced work environment, the health of employees can often take a back seat to the pressures of meeting deadlines and maintaining productivity. However, maintaining a healthy workforce is crucial for fostering a positive work environment and ensuring long-term organizational success. Regular health check-ups at the office serve as an effective means to address this challenge, ensuring that employees have access to necessary health assessments without the need to disrupt their work routines. The positive impact of these initiatives not only improves employee well-being but also reinforces the company’s commitment to a healthier workforce. This blog will delve into why these check-ups are crucial and provide insights into how they can be effectively implemented in the workplace. Aegis Lifesciences Leads the Way in Workplace Wellness It’s often said that prevention is better than cure, a principle that Aegis Lifesciences upholds in its commitment to employee he
Read more

Role of Surgi-ORC® Fibril and SURGISPON® in Posterior Fossa Tumor Resections

Image
  In posterior fossa tumor resections, Surgi-ORC® Fibril and SURGISPON® play crucial roles in facilitating a successful surgery and promoting optimal patient outcomes. Here's how they contribute to the surgical process: Hemostasis : One of the primary roles of both Surgi-ORC® Fibril and SURGISPON® is to assist in achieving hemostasis, which is the control of bleeding during surgery. Posterior fossa tumor resections can involve intricate procedures near sensitive structures such as the brainstem and cranial nerves, where bleeding must be carefully managed to maintain a clear surgical field and prevent complications. Surgi-ORC® Fibril and SURGISPON® are applied to bleeding surfaces to promote clot formation and minimize bleeding, thus enhancing visibility and surgical precision. Tissue Protection : During posterior fossa tumor resections, it's essential to protect delicate neural tissues from damage during surgical manipulation. Surgi-ORC® Fibril and SURGISPON® act as physical ba
Read more

Revolutionizing Total Knee Arthroplasty: The Role of ORC in Bleeding Control

  Effective   bleeding control   remains a formidable challenge in   modern surgery , particularly in orthopedic procedures where managing bleeding from the exposed or cut surface of cancellous bone is a critical concern.   Total knee arthroplasty   (TKA), a prevalent surgery for severe knee arthritis within orthopedics, is notably associated with significant blood loss due to extensive bone cutting and exposure of a large surface area of cancellous bone [1]. Challenges in TKA: Patients undergoing primary TKA are particularly susceptible to significant intraoperative and postoperative blood loss, leading to potential complications such as pain, decreased range of motion, and delayed recovery. With an aging population and increased life expectancy, the annual incidence of TKA procedures is expected to rise, reaching an estimated 3 million in the United States by 2030 [2]. Role of Absorbable Haemostatic Agents: To address bleeding challenges in orthopedic surgeries, particularly in TKA,
Read more